stem cell therapy in india Archives - Eye Stem Cell Center

India is increasingly recognized for advancements in ophthalmic regenerative medicine. For patients facing progressive retinal or optic nerve damage, stem cell therapy is being explored as a supportive treatment under controlled medical protocols. Conditions Being Studied Stem cell therapy in India is explored for: Leber’s hereditary optic neuropathy Optic nerve atrophy Retinal dystrophies Autoimmune-related optic

Vision loss caused by retinal and optic nerve disorders can deeply impact quality of life. In India, stem cell therapy is being explored as a regenerative option for selected degenerative eye conditions under specialized medical supervision. Understanding Retinal Degeneration The retina is a delicate neural tissue responsible for transmitting visual signals to the brain. Conditions

Vision disorders involving the retina and optic nerve require specialized evaluation and long-term management. These conditions often progress gradually and can significantly affect daily life. Eye Stem Cell Center focuses on responsible, regenerative ophthalmic approaches designed to support patients facing degenerative retinal and optic nerve disorders while maintaining strict clinical and ethical standards. The retina

Rod and cone dystrophies including retinitis pigmentosa, cone- rod dystrophy and related inherited retinal  declensions — precipitously destroy photoreceptors and can lead to severe vision loss. Traditional treatments  substantially manage symptoms or slow progression; they infrequently restore lost photoreceptors. lately,  still, stem cell – grounded approaches have  surfaced as one of the most promising strategies

Egypt is facing growing challenges in eye health due to rising diabetes prevalence, increasing life expectancy, environmental factors, and limited access to specialized ophthalmic care in rural and underserved regions. While urban centers offer modern eye hospitals, a large segment of the population still lacks early diagnosis and advanced treatment options. As a result, common

Macular dystrophies —  inheritable  diseases that damage the central retina have long posed a tough challenge progressive central vision loss with limited treatment options. Over the once many times, still, regenerative  drug has moved from hopeful laboratory  wisdom into  mortal trials. In India, experimenters and biotech startups are now  rephrasing stem- cell  wisdom into concrete

Glaucoma remains one of the world’s leading causes of  unrecoverable blindness, primarily by causing progressive damage to the retinal ganglion cells( RGCs) and the  optical nerves. Over time, this damage can lead to  optical atrophy — a degenerative thinning of the  optical nerves which standard treatments, similar as intraocular- pressure( IOP) – lowering  specifics or

Leber natural amaurosis( LCA) is a group of inherited retinal  diseases that beget severe visual impairment or blindness from immaturity. Traditionally,  operation  concentrated on low- vision support and  decelerating progression, but the last decade has seen  rapid-fire advances in  inheritable  drugs and regenerative  curatives. For families in India, stem cell – grounded approaches are arising

Glaucoma remains one of the world’s leading causes of  unrecoverable blindness, primarily by causing progressive damage to the retinal ganglion cells( RGCs) and the  optical nerves. Over time, this damage can lead to  optical atrophy — a degenerative thinning of the  optical nerves which standard treatments,  similar as intraocular- pressure( IOP) – lowering  specifics or

Overview of Glaucoma Glaucoma is a chronic condition where the normal function of the optic nerve is slowly compromised. It is usually linked to raised intraocular pressure, but other factors, including reduced blood flow to and damage of the optic nerve, are also involved. It may be slow and painless in onset, making it all the more